Quantum Biopharma Ltd.

Quantum Biopharma Ltd.

Biotechnology • Healthcare • Toronto, ON, United States • QNTM (NCM)

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.

833 571 1811 55 University Avenue, Toronto, ON M5J 2H7, Canada

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - The Newark Advocate
The Newark Advocate • Dec 29
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - Rockford Register Star
Rockford Register Star • Dec 24
Long-term safety tests finish for new multiple sclerosis drug candidate - Stock Titan
Stock Titan • Dec 23
Quantum BioPharma Ltd. Announces Corporate Updates - Yahoo Finance
Yahoo Finance • Oct 29
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock - GlobeNewswire
GlobeNewswire • Oct 8

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Quantum Biopharma Ltd. had layoffs?
No layoff events have been recorded for Quantum Biopharma Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is Quantum Biopharma Ltd. in?
Quantum Biopharma Ltd. operates in the Biotechnology industry, within the Healthcare sector.
Is Quantum Biopharma Ltd. a publicly traded company?
Yes, Quantum Biopharma Ltd. is publicly traded under the ticker symbol QNTM on the NCM. The company has a market capitalization of approximately $0.03 billion.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered in Toronto, ON, United States at 55 University Avenue, Toronto, ON M5J 2H7, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.